Biotechnology Companies Worldwide
Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 796 companies in this sector. The largest share of listings is based in United States (US). Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
796 companies
United States (US) top country
Location
Category
Biotechnology
List of Biotechnology companies in All locations
796 companies
Sort by
Accelerate your cell-line engineering projects with powerful automation solutions and custom services!
Biotechnology
Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. We sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including GE Healthcare, Thermo Fisher Scientific Inc., and VWR. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, and Spain and sales facilities in France and Canada.
Biotechnology
Stemnovate provides innovative technologies for drug screening and safety testing. We have developed state of the art platform technologies, underpinned by experience in tissue procurement, cell biology, high through put imaging and microfluidics. We provide a customer friendly and flexible platform for human drug discovery which overcome many of the limitations associated with mammalian cell lines and in vivo models.
Biotechnology
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.
Biotechnology
Glencoe Software is committed to the delivery of innovative, scalable, commercial software solutions for its clients. We make the viewing, sharing, analysis and management of life science images and data within a single software framework simple. We take the guesswork out of formatting, file conversions, sharing, storage, and – to some extent – even analysis. Glencoe’s products are utilized in thousands of labs and publications around the world. Our dedicated support to our customers is evident in all that we do. Let us help you manage and share your data, images and videos in an efficient and compelling way.
Biotechnology
Secure, transparent compression for genomic data.
PetaGene helps organisations manage their rapidly growing genomic data using transparent lossless compression and encryption. PetaGene's multi award-winning software significantly reduces storage and access costs, accelerates transfers and analyses, and simplifies cloud integration for genomic data. It also helps manage compliance through encryption and deep auditing. Large pharma, commercial, clinical and academic labs use PetaGene to cut costs, reduce turn-around times, and add new capabilities to their genomic workflows without disruption to their users or technology framework.
For more information, please visit: https://www.petagene.com
Biotechnology
We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets.
Biotechnology
Mylab is a health-tech company that develops & commercialises molecular diagnostic kits and instruments to empower labs in obtaining Reliable, Timely & Actionable answers. We are a company driven by Science and Technology , and our goal is to outpace others in delivering high-quality healthcare solutions to improve lives.
What makes Mylab a perfect choice is the power of certainty, providing insights, support, expertise, services, and solutions with an indispensable share. As a leader in providing high-end healthcare solution, we believe it is our duty to be at the forefront of disease control and clinical management.
Biotechnology
Alpha Genesis® Inc. (AGI) provides the highest quality nonhuman primate products and bio-research services world-wide, with a customer base that extends across North America, Europe, and Asia. The Alpha Genesis Primate Research Center is a full-service facility that offers Nonhuman Primates for Biomedical Research, Contract Research and Consultation, Primate Housing and CDC Quarantine, and Biological Products and Materials. AGI maintains 100+ acres of primate breeding and holding facilities, and our large inventory of monkeys allows us to best serve your primate research needs. All AGI monkeys are of optimal health and are readily accessible for immediate availability and use. Individual monkey health records available to prospective clients upon request.
Principal research areas currently include: Aging and Metabolic Diseases, Immunogenetics and Immonology, Reproduction, Neurobiology, Physiological Ethology, Psychobiology. Recent research focus: embryonic stem cells, AIDS vaccine research, women's health, developmental disorders, glaucoma and presbyopia, osteoporosis, Parkinson's, movement disorders, diabetes, drug addiction, and obesity.
Veterinary training is available in primate biology, medicine, biomedical research, and behavior. Unique opportunity to work directly with monkeys. Educational opportunities are available to students case-by-case. Interested students should submit a research plan to info@alphagenesisinc.com. Outreach activities are also considered.
Since its inception AGI has grown to serve a broader customer base as we have strengthened our dedication to providing the very best and most cost-effective research and development support to the scientific community. Each AGI employee that works within our AAALAC accredited facilities is highly qualified and carefully trained specifically to complete the job you hired us to do.
If you have questions or would like to place an order, please e-mail AGI at info@alphagenesisinc.com or call toll-free 866.789.MONK (6665). Visit us on the web at www.alphagenesisinc.com or at www.primateresearch.com
Biotechnology
Talent Consultancy -Understanding people, using our approach, enables you to determine how well your staff are engaged, help them to think through their career and put in place succession and people expansion plans.
Coaching - I provide you with an opportunity to evaluate your unique contribution in the workplace, work effectively in teams and explore how to make the most of your career.
Team Coaching -We use group online sessions to build respect and trust within and between small teams. Everyone is brilliant; we just need to understand how these skills can best be utilised.
Senior Recruitment -We can deliver senior level executive search assignments built on a strong understanding of your organisation. This is done with our recruitment partner - Horton International.
Biotechnology
Astell Scientific has been a world leading manufacturer and supplier of laboratory, pharmaceutical & hospital autoclaves and sterilizers for over a century, shipping thousands of autoclaves around the world.
Through continuing investment in product development and information technology, Astell Scientific offers high quality products manufactured in the UK and backed up by efficient order processing and prompt dispatch.
During the last twenty years Astell Scientific have developed a reputation as specialist manufacturers of sterilization equipment, producing a wide range of front and top-loading PLC controlled Autoclaves and Sterilizers designed to meet the exacting demands of the modern Laboratory, Pharmaceutical and Medical professionals.
All Astell Scientific autoclaves, Steam Generators and Effluent Decontamination systems (EDS) incorporate the latest innovations in control system technology, providing colour touchscreen controllers, on screen tutorial, 5 password levels, multiple cycle programming, secure data archiving, and delayed start facility all included as standard throughout the range.
These include:
Circular section units from 30-330 litres
Square Section units from 125 - 2000 litres
Steam Generators up to 72 kW
Effluent Decontamination Systems (EDS) designed to your needs
Other items we produce:
Nelldorn Glassware Dryers
Hearson Tobacco Ovens
#autoclave #sterilizer #sterilisation
Biotechnology
LabCentral is Cambridge, MA's premier network of shared laboratory spaces and scientific communities, designed to jumpstart the launch of promising early-stage life-sciences companies. Home to 100+ great teams and growing fast! Providing first-class operational support, curated events and programming, and access to a diverse network of sponsors, LabCentral prepares entrepreneurs and scientists to accelerate scientific innovation in service of human health.
Biotechnology
Founded in 2004 and headquartered in Warrington, Cheshire, AlphaBiolabs is a leading and award-winning provider of DNA, drug, alcohol, and health testing services across the UK.
We employ state-of-the-art techniques to provide timely, accurate, and cost-efficient testing to meet a range of needs. Our client base includes businesses of all sizes across every sector, family and immigration law solicitors, social services, local authorities, members of the public, and the media.
Our laboratory is accredited to the international quality standards UKAS ISO 17025 and ISO 9001, and our test results are accepted by the Ministry of Justice, the Home Office, UK Visas and Immigration, HM Passport Office, Border Force, and Immigration Enforcement.
We also operate a network of walk-in centres in 21 locations across the UK and Ireland.
Biotechnology
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; and VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer. Barinthus Biotherapeutics’ proven scientific expertise, diverse portfolio and focus on pipeline development uniquely positions the company to navigate towards delivering treatments for people with infectious diseases, autoimmunity and cancers that have a significant impact on their everyday lives.
Biotechnology
Wilk is at the forefront of cell-grown milk production, developing solutions that answer the long-term needs of the milk markets.
Biotechnology
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®.
Biotechnology
Theragent Inc is a startup biotechnology company that specializes in developing and manufacturing novel personalized immunotherapies for cancer patients around the world. Our envisioned cGMP manufacturing facility is based in Southern California to support our local and global partners, including biotech companies, hospitals, academic centers, and research organizations.
Biotechnology
Haier Biomedical provides innovative, robust and sustainable products and services to the life science sector. We help organisations with their challenges by offering market-led, low-impact, quality and technologically-advanced products, which are trusted by scientists globally.
As the local hub for Haier Biomedical our approach is to build partnerships with our clients, providing a personal touch, going the extra-mile and delivering value.
Biotechnology
Oxford Medical Products (OMP) is developing a safe, effective and affordable breakthrough technology for weight loss that uses novel co-polymer technology, which occupies space in the stomach, reducing hunger and leading to significant weight loss. In addition, further to our successful phase 1 clinical trial we are now developing our core technology as a gastro-retentive drug delivery system.
Led by a team of scientists, medical professionals and entrepreneurs who have come together to solve one of the world’s toughest and most urgent medical challenges.
Biotechnology
BioMedha is a UK-based pre-clinical CRO providing in vitro biology expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process. BioMedha expertise includes:
• HTA authorized establishment with on-site blood donor panel
• Immunology, Oncology, Immuno-oncology, and inflammation studies
• Target validation, assay development, screening, and MOA studies
• Whole blood and Immune cell functional assays
• Flow cytometry capabilities
• Cytokine assays and Luminex multiplexing
• Cell imaging expertise
• Expression studies (protein levels, mRNA levels, and surface expression)
• Plate reader-based assays (Fluorescence, Luminesce, Absorbance, FP, FRET, BRET, Alphascreen, HTRF)
• Functional assays (e.g. signalling pathways, bioassays)
• GPCRs: assay development and screening
• Protein-Protein Interactions (PPI)
• Enzyme activity
• Discovery Toxicology studies
We are a small but passionate team of scientists with substantial experience in the pharmaceutical and biotech industries, focused heavily on pre-clinical drug discovery biology. We serve clients in pharma, biotech, virtual companies, spin-outs, and academic institutions.
Biotechnology
XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...)
In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.
Biotechnology
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting paradigms where it’s needed most – starting with narcolepsy. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options.
At Avadel, our core values foster an atmosphere of transformation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with sleep disorders.
Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
Biotechnology
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics under development on our platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, cardiology and immunology. Consistently named a best place to work, we foster an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in our mission to provide patients everywhere access to safe and effective prescription digital therapeutics.
NOTE: Fake job advertisements and offers are increasingly appearing on the internet. If you have encountered a job posting or have been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond and report it to the Federal Trade Commission and to recruitment@clicktherapeutics.com.
Other than your email address or telephone number, which you may provide via a job application portal, Click Therapeutics will never ask you to provide personally identifiable information about yourself (such as a Social Security Number or Driver’s License Number) via a messaging application.
Biotechnology
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines
*in collaboration with AbbVie
Biotechnology
At T-Cypher Bio we generate novel TCR-based therapeutics that have the potential to transform the treatment of immune-mediated disease. Our proprietary platforms provide unique insight into T cell based immunity in both health and disease. High throughput, high-resolution profiling of the immune synapse enables us to map the intracellular target space and profile T cell specificity. These platforms not only give us tools to build highly innovative drugs, but also build immune system data sets of unprecedented size. These data sets support cutting edge computational modelling of T cell repertoires which will revolutionize T cell immunology.
To build our oncology pipeline, we validate novel, shared, tumour-specific targets and identify panels of rare functionally-defined T cell clones. The unique TCRs we identify are the foundation of our broad pipeline of lifesaving therapeutics for underserved solid tumour patients.
Biotechnology
MiCroBial Technologies create a powerful composite biocatalyst from a unique blend of microorganisms, enzymes, and co-factors. This composite biocatalyst co-exists with existing wastewater biology to enhance their rate of reaction, resulting in a more efficient biological treatment process. The technology fits into a relatively new scientific field called Bioaugmentation that presents a simple and cost effective way to solve wastewater treatment, solid waste treatment, aquaculture problems without expensive capital enhancements. Unique to MiCroBial technologies is the ability to reduce the required time for bacteria to adapt to new waste streams. MiCroBial technologies enables a rapid biological response to load and flow variation, a key differentiator to conventional Bioaugmentation which rely on product formulations specific to a waste stream. MiCroBial Technologies provide variety of microbiological products for different problems wastewater treatment so that clients can achieve their pollution norms.
Biotechnology
Hazel Technologies develops products that extend the shelf life of produce. Our customers include some of the largest produce growers in the world. For more information, visit www.hazeltechnologies.com or email info@hazeltechnologies.com
Biotechnology
Incisive Technologies, based in Melbourne Australia, is developing a novel diagnostic for the oral health sector, which is highly sensitive in detecting early-stage tooth decay. The product is a dental paint applied to the teeth by an oral health professional (dentist, orthodontist, hygienist) during regular check-ups to detect problems early so that preventive measures can be used, including remineralisation and better patient education. This approach to oral health helps patients avoid painful and costly restoration due to cavities and assists dentists to implement best-practice preventive care.
Biotechnology
DSI is a pioneering biomedical research company focused on preclinical systems physiology and pharmacology.
The recognized global leader in physiologic monitoring, DSI offers telemetry, instrumentation, and software and services that help advance science. DSI serves many industries including: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, the Medical Device Industry, Government, and Biotechnology companies. We offer solutions that are tailored specifically to meet the unique research needs of our customers. DSI is a division Harvard Bioscience Inc.
Biotechnology
We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant ("MDR”) bacterial infections with high unmet need. Our pipeline consists of three mid to late-stage clinical assets. Tebipenem HBr is in Phase 3 development, with the potential to be the first broad-spectrum oral carbapenem to treat complicated urinary tract infections ("cUTIs”) including acute pyelonephritis, caused by certain microorganisms, in adult patients. SPR206 is a Phase 2 ready IV-administered antibiotic being developed as an innovative option to treat MDR Gram-negative bacterial infections in the hospital setting. SPR720, the development of which was recently suspended, is a Phase 2 investigational oral agent for the first-line treatment of nontuberculous mycobacterial ("NTM”) pulmonary disease, a rare disease. As previously disclosed, following the SPR720 program suspension, we are evaluating other potential paths forward as the remaining data are collected and analyzed.
Biotechnology
Official account of the National Center for Biotechnology Information (NCBI) at the National Library of Medicine. NCBI serves as an international resource for the scientific research community - providing access to public databases and software tools for analyzing biological data, as well as performing research in computational biology.
The NCBI was established in 1988 by an act of the United States Congress as division of the National Library of Medicine at the National Institutes of Health, with a mission to find new approaches to deal with the increasing volume and complexity of biological data in order to facilitate the understanding of genes and their role in health and disease.
The NCBI is made up of multidisciplinary research and development teams composed of molecular biologists, biochemists, structural biologists, clinicians, mathematicians, and computer scientists who:
Archive: Gather scientific and medical research data from around the globe
• Serve as the largest repository of the world’s primary biological research data
• Produce curated datasets to enhance the value and usability of the primary data
Access: Develop systems for discovering and integrating scientific and medical data
• Create search tools and data cross-referencing mechanisms
• Display and enable download of information from the world's largest collection of biological data
Advance: Promote understanding of processes that effect health and disease
• Perform cutting-edge research in computational biology
• Design and build algorithms, programs and systems for analysis of biological data
• Provide support and training through a varied and vigorous outreach program
.
Biotechnology
Based in Franklin, Tenn., Pierian Biosciences is a privately held life sciences company offering the development and delivery of innovative, treatment-directing information, allowing providers to design patient-specific strategies that improve outcomes, quality of life and lower the cost of cancer care. The company’s technology includes the ChemoINTEL and, ImmunoINTEL platforms. Pierian Biosciences has their laboratory in Franklin, Tenn. and business offices in Franklin, Tenn and the UK.
Biotechnology
Ariadne Solutions applies artificial intelligence and natural language processing to bioanalytical data to accelerate data review and offer levels of sensitivity and granularity not possible before. The company was founded on the belief that the right tools paired with bioanalytical expertise can help biopharmaceutical scientists better identify and predict risk early in drug development, while accelerating drug development timelines and delivering treatments to the patients who need them most.
Biotechnology
Science Care sets the standard of excellence for the donation and responsible use of human tissue for medical research, training and professional education.
Science Care is the first organization to be accredited by both the American Association of Tissue Banks (AATB) and the Accreditation Council for Continuing Medical Education (ACCME), marks of excellence that speak to our quality, safety, and respect for the donor, medical researchers and educators.
We have trained over 55,000 surgeons and physicians at our medical training facilities. We’re headquartered in Arizona, with additional facilities in California, Colorado, Florida, Pennsylvania, Illinois, and Texas.
Science Care whole body donors have accelerated research on many fronts leading to the development of new medical devices and safer, more effective treatment for patients. At Science Care, we provide the opportunity to make possible donors' and their families' wishes to leave a lasting legacy.
Safety: Our donor evaluation process includes a complete medical and social history of each donor, and safe blood testing to ensure the safety and suitability of the donation. We meet or exceed all OSHA standards, including a hazardous communication plan and stringent training including extensive policies and procedures to ensure compliance and safety.
Consistency: Science Care was founded in 2000, and has a long history of linking whole body donors with medical researchers and educators, and we actively lobby for responsible non-transplant tissue banking.
Staffing: We have a highly trained, professional staff, including our licensed medical director and several Certified Tissue Bank Specialists. All employees go through a detailed background check before hiring.
Availability: We provide outstanding customer support and we respond promptly to all inquires. We are available 24 hours a day, seven days a week via our toll-free phone line, 800.417.3747.
Biotechnology
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners and select acquisitions.
The Company’s proprietary antibody technology platforms Harbour Mice® generate fully human monoclonal antibodies in two heavy and two light chain (H2L2) format, as well as heavy chain only (HCAb) format. Building upon the HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) are capable of delivering tumor killing effects unachievable by traditional combination therapies. Integrating Harbour Mice® with single B cell cloning platform, our antibody discovery engine is highly unique and efficient for development of next generation therapeutic antibodies.
For more information, please visit www.harbourbiomed.com
Biotechnology
Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage.
Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage.
Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment
Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. This commitment is achieved through listening to our customers, bringing together proven manufacturers and systems to translate customer needs into innovative and reliable diagnostic solutions. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment
Biotechnology
7 Hills Pharma is a clinical-stage pharmaceutical company developing first-in-concept, oral immune stimulants to augment a broad range of immunotherapies for the treatment of drug-resistant solid tumors and prevention of infectious diseases.
Our compounds are selective, allosteric, systemic activators of the integrins LFA-1 and VLA-4 that have been shown in preclinical models to augment the effectiveness of prophylactic vaccines for influenza, COVID-19, Tuberculosis, and Chagas disease, as well as checkpoint inhibitors for solid tumors. Our lead molecule, 7HP349, has completed a Phase I first-in-human clinical trial, demonstrating oral bioavailability and an exceptional safety profile at exposures well exceeding therapeutic levels.
Biotechnology
NCBiotech is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to transform North Carolina and its life sciences technology-based economic development through innovation, commercialization, education, and business growth.
Biotechnology
STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. There are more than 150 RNA modifications reported and approximately 300 RNA modifying enzymes which represent novel therapeutic targets.
STORM has leveraged its first mover advantage to establish a novel drug discovery and RNA analytics platform leading to the identification of novel targets and a proprietary pipeline of first in class small-molecule drug candidates for potential use in oncology, inflammation, viral infections, and CNS diseases.
The pipeline is exemplified by STORM’s METTL3 inhibitor (STC-15) for which an IND has been filed with the FDA to support initiation of a Phase I clinical trial in cancer patients in 2022. STC-15 represents the first RNA modifying enzyme inhibitor to enter clinical evaluation in humans. Additional candidates are planned for advancement into IND-track activities in 2023.
STORM has built an experienced R&D team who occupy modern, well-equipped laboratories on the Babraham Research Campus near Cambridge, UK. The company’s proprietary in house research is complemented by outsourcing of some discovery activities to high quality CRO partners (e.g., Evotec) enabling STORM to operate a cost efficient and flexible model.
Biotechnology
GBA Group is an international life science services company with over 3,000 employees and a wide range of analytical, logistical and specialist services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water and the environment.
The group stands for outstanding technical expertise, efficient processes and full focus on customer benefits with regard to its activities in the fields of research, product development, market development and consumer protection. With its services, GBA Group directly and indirectly makes a sustainable contribution to health, the environment and society.
Biotechnology
By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to:
1. Improve human health: Creating highly selective and controllable promoters and gene expression cassettes for novel gene and cell therapy systems. Improving the efficiency of biologics production by increasing protein yields in upstream manufacturing processes.
2. Engineer biology: Harnessing synthetic biology to make promoters for a wide array of chassis organisms used in Industrial Biotech. Creating switches and gene circuits that can be employed in the metabolic engineering applications.
3. Enable traits discovery: Designing tissue-selective plant synthetic promoters active across different crop species for Agricultural Biotech applications. Using plant genomics to facilitate the design of environmentally-regulated and pathogen-responsive promoters.
Biotechnology
SHEPHERD is a biopharma company by patients for patients. SHEPHERD helps match cancer patients to the best treatments available to them. To learn more, visit shepherd.bio.
BioSpace's Top 20 Companies to Watch in 2018
Forbes 30 Under 30
Biotechnology
CliniSciences commercialises reagents (antibodies, recombinants, ELISA kits, RNAi, cDNA clones, probes, PCR/qPCR reagents...) to diagnostic and research labs. As very dynamic company, we do our best to be close to our customers' needs in terms of high quality reagents that we propose and in terms of service that we provide (search for a particular antibody, technical support, delivery time, etc.)
Our principal assets for better serving you : adaptability, flexibility, reactivity and naturally the competence of the technical specialists at your service.
Biotechnology
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy
Biotechnology
Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results.
Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine.
Toward life-changing therapies, and brighter futures.
Toward More™
Biotechnology
Tozaro is developing a novel suite of reagents to help transform the development and manufacture of viral vectors in cell and gene therapy. Operating at the intersection of chemistry and biology, Tozaro’s smart polymers are evolving existing analytical and purification processes to realize a future where advanced therapies are accessible to all.
Biotechnology
Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Our goal is to have at least one antibody to every human expressed gene in human genome.
In Phase I of our business plans, we vastly expand the scope and availability of antibody reagents for the research market by taking a genome-wide approach to the high throughput production of human protein and antibody. There products are marketed through a combination of E-commerce based direct sales and a multi-tiered, sales network of over 49 distributors around the world.
Starting from Year 2009 to 2013, in Phase II of the business plans, we have diversified into the systems arena focusing on antibody pairs, ELISA kits and instrumentation for rare cell isolation. In Phase III, we focus on in vitro diagnostics development concentrating on non-invasive, liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Now in Phase IV (Year 2017 and later), we have focused on drug development specializing on immunotherapy. The value-added business has set the path of company's future growth and provided opportunity for Abnova to contribute to the biotech industry at large.
We welcome researchers, biotech, and pharmaceutical companies to work with us and succeed together!
Biotechnology
OPERON is a private Spanish company founded as a family business in 1973 engaged during the last 50 years in R&D innovation and manufacturing of In Vitro Diagnostics IVD. Active in the clinical diagnostics, in the veterinary field and in the food industry checking frauds in milk. The company is ISO 9001:2000 and ISO 13.485:2008 certified complying with cGMP .
OPERON employs above 80 highly skilled and experienced people, 20 of them involved in R&D work.
OPERON controls the whole added value chain of a new IVD test. Starting with the design of the raw materials, producing the kits and selling the IVD test to the end users through distributors or through its partners channels.
OPERON is active in 4 different areas:
1. Lateral Flow Tests, more than 20 years experience. Working on a 3rd quantitative generation using fluorescent particles and a portable Point Of Care POC reading instrument.
2. Molecular Biology tests, based on different technologies: hybridization on strip (Opegen products), and Real Time PCR.
All these products are based on the capture with specific probes of DNA fragments amplified by a conventional PCR.
3. Raw Materials: Develops Monoclonal Antibodies and Recombinant Antigens and produces them also in bioreactors and fermentors at industrial scale.
4. All our know how is available as a service. Development of new Monoclonal Antibodies and Recombinant Antigens, large scale production, purification. The development of innovative IVD tests is our most challenging task.
Exporting more than 90% of its turnover mainly to Europe, US, Japan and 50 more countries. OPERON currently sells its brand name products using a network of distributors around the world, but our largest activity is to manufacture OEM kits or to supply in bulk to leading companies in the IVD sector.
Biotechnology
Mission: Deliver low-cost, non-invasive in vitro diagnostics (IVDs) for high-incidence diseases at the point-of-care.
Approach: Using Raman Spectroscopy and Surface Enhanced Raman Spectroscopy (SERS) to achieve detection beyond current standard-of-care IVDs. Existing research supports identifying target diseases in urine using this approach.
Focus: Serox has attracted a fantastic array of scientific and medical advisors and has established clinical relationships to help validate its approach, initially in bladder, prostate and kidney cancers. The intention is to ‘bundle’ tests which may be requested together, say when a patient presents with blood in their urine. Women’s cancers will follow, along with point-of-care speciation of Urinary Tract Infections.
Differentiation: Serox displaces chemistry with photonics and Machine Learning, to allow urinalysis to avoid invasive procedures (blood taking, biopsy cystoscopy). Serox is following a data-focussed path that will lead to the personalisation of IVD.
Timeliness: Raman Spectroscopy and SERS have long been used in advanced laboratories. The price of lasers and detectors is falling, and the usability and deployability of Raman Spectrometer improving. Machine Learning allows the ability to diagnose from the aggregate of Raman shifts in complex liquids. Together this unlocks the use of Raman Spectroscopy as a routine diagnostic.
Outcome: Serox offers the prospect of a low-cost cartridge that be used remotely to acquire a urine sample, or in a clinic at the point-of-care, that can be processed using a desktop analyser in less than three minutes to provide an answer with a high Negative Predictive Value, and sensitivity / specificity in line with the current standard-of-care. This could reduce referrals to cystoscopy and biopsy, ultimately transform screening, and reduce the unnecessary use of broad-spectrum antimicrobials.
Biotechnology
Cambridge Scientific Products offer an unmatched inventory of quality refurbished laboratory equipment. We regularly save our customers 40-60% off list prices.
Biotechnology
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Oxford, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@iotasciences.com | https://www.iotasciences.com?utm_source=linkedin&utm_medium=button&utm_content=visit-website | ||
Holliston, United States (US) | Science and Engineering Science and Engineering | 500-1000 | info@harvardbioscience.com | http://www.harvardbioscience.com | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@stemnovate.co.uk | http://www.stemnovate.co.uk | ||
Düsseldorf, Germany | Science and Engineering Science and Engineering | 20-30 | info@abalos-tx.com | http://www.abalos-tx.com | ||
Seattle, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@glencoesoftware.com | http://www.glencoesoftware.com | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@petagene.com | https://www.petagene.com/ | ||
Copenhagen, Denmark | Science and Engineering Science and Engineering | 2-10 | info@orbismedicines.com | http://www.orbismedicines.com | ||
Lonavala, India | Science and Engineering Science and Engineering | 100-150 | info@mylabglobal.com | https://mylabglobal.com/ | ||
Yemassee, United States (US) | Science and Engineering Science and Engineering | 50-100 | info@alphagenesisinc.com | http://www.alphagenesisinc.com | ||
Bristol, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@biosocius.com | http://www.biosocius.com | ||
Sidcup, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | sales@astell.com | https://www.astell.com | ||
Cambridge, United States (US) | Science and Engineering Science and Engineering | 100-150 | info@labcentral.org | http://labcentral.org | ||
Warrington, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | info@alphabiolabs.co.uk | http://www.alphabiolabs.co.uk | ||
Harwell, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | info@barinthusbio.com | https://www.barinthusbio.com | ||
Rehovot, Israel | Science and Engineering Science and Engineering | 10-20 | info@wilkismilk.com | https://wilkismilk.com/ | ||
ABBOTSFORD, Australia | Science and Engineering Science and Engineering | 20-30 | info@starpharma.com | http://www.starpharma.com/ | ||
Los Angeles, United States (US) | Science and Engineering Science and Engineering | 50-100 | help@theragent.com | http://www.theragent.com | ||
Sunbury on Thames, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | marketing@haierbiomedical.co.uk | http://www.haierbiomedical.co.uk/ | ||
Witney, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@oxfordmedicalproducts.com | https://www.oxfordmedicalproducts.com | ||
Nottingham, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@biomedha.com | https://biomedha.com | ||
Evry, France | Science and Engineering Science and Engineering | 20-30 | contact@xentech.eu | http://www.xentech.eu | ||
Dublin, Ireland | Science and Engineering Science and Engineering | 100-150 | info@avadel.com | http://www.avadel.com | ||
New York, United States (US) | Science and Engineering Science and Engineering | 100-150 | info@clicktherapeutics.com | http://www.clicktherapeutics.com | ||
San Diego, United States (US) | Science and Engineering Science and Engineering | 1000-5000 | info@neurocrine.com | http://www.neurocrine.com | ||
Oxford, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@tcypherbio.com | https://tcypherbio.com/ | ||
Solapur, India | Science and Engineering Science and Engineering | 2-10 | support@microbialtech.com | http://www.microbialtech.com | ||
Chicago, United States (US) | Science and Engineering Science and Engineering | 50-100 | info@hazeltechnologies.com | http://hazeltechnologies.com | ||
Melbourne, Victoria, Australia | Science and Engineering Science and Engineering | 2-10 | info@incisive-technologies.com | https://www.incisive-technologies.com/ | ||
Saint Paul, United States (US) | Science and Engineering Science and Engineering | 200-500 | support@datasci.com | http://www.datasci.com | ||
Cambridge, United States (US) | Science and Engineering Science and Engineering | 20-30 | info@sperotherapeutics.com | http://www.sperotherapeutics.com | ||
Bethesda, United States (US) | Science and Engineering Science and Engineering | 500-1000 | info@ncbi.nlm.nih.gov | https://www.ncbi.nlm.nih.gov | ||
Franklin, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@pierianbio.com | http://www.pierianbio.com | ||
Lawrence, United States (US) | Science and Engineering Science and Engineering | 2-10 | info@ariadnesolutions.com | http://www.ariadnesolutions.com | ||
Phoenix, United States (US) | Science and Engineering Science and Engineering | 100-150 | info@sciencecare.com | http://www.sciencecare.com | ||
Cambridge, United States (US) | Science and Engineering Science and Engineering | 200-500 | info@harbourbiomed.com | http://www.harbourbiomed.com | ||
Wetherby, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@sterilab.co.uk | http://www.sterilab.co.uk/ | ||
Houston, United States (US) | Science and Engineering Science and Engineering | 2-10 | Contact@7HillsPharma.com | http://www.7hillspharma.com | ||
Research Triangle Park, United States (US) | Science and Engineering Science and Engineering | 100-150 | marketing@ncbiotech.org | http://www.ncbiotech.org | ||
Cambridge, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | info@stormtherapeutics.com | http://www.stormtherapeutics.com | ||
Hamburg, Germany | Science and Engineering Science and Engineering | 1000-5000 | service@gba-group.de | https://www.gba-group.com | ||
Edinburgh, United Kingdom (UK) | Science and Engineering Science and Engineering | 2-10 | info@chromatinbio.com | http://www.chromatinbio.com | ||
Boston, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@Shepherd.bio | http://www.Shepherd.bio | ||
Nanterre, France | Science and Engineering Science and Engineering | 50-100 | info@clinisciences.com | https://www.clinisciences.com/en/ | ||
Boston, United States (US) | Science and Engineering Science and Engineering | 1000-5000 | info@alexion.com | http://www.alexion.com/ | ||
Stevenage, United Kingdom (UK) | Science and Engineering Science and Engineering | 100-150 | contact@spurtherapeutics.com | http://www.spurtherapeutics.com | ||
Bedford, United Kingdom (UK) | Science and Engineering Science and Engineering | 20-30 | marketing@tozaro.com | http://www.tozaro.com | ||
Taipei, Taiwan | Science and Engineering Science and Engineering | 50-100 | sales@abnova.com | http://www.abnova.com | ||
Cuarte de Huerva, Spain | Science and Engineering Science and Engineering | 50-100 | sales@operon.es | http://www.operondx.com | ||
Long Hanborough, United Kingdom (UK) | Science and Engineering Science and Engineering | 10-20 | info@serox.ai | https://www.serox.ai | ||
Watertown, United States (US) | Science and Engineering Science and Engineering | 10-20 | info@cambridgescientific.com | https://www.cambridgescientific.com/ |
50/796 results
Frequently asked questions
Updated 23 October 2026
What is Enterprise League?
Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.
Is it free to list my company?
Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.
How does verification work, and what does it cost?
Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.
Where does the company information come from?
Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.
How do I claim or correct my company’s profile?
Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.